United States
Arnold & Porter
An overview of the upcoming congressional schedule, including key dates in April 2024
Dickinson Wright PLLC
The Food and Drug Administration regulates foods and beverages, drugs and medical devices, biologics, dietary supplements, tobacco products, veterinary products, and cosmetics.
Akin Gump Strauss Hauer & Feld LLP
The Department of Health & Human Services' Office of Inspector General (HHS OIG) and U.S. Department of Justice (DOJ) have published important guidance and recommendations for pharmaceutical...
K&L Gates
In this two-part Triage series, Gina Bertolini, Stephen Page, and Sarah Staples-Carlton discuss an old health care regulatory doctrine that has new relevance in a post-COVID world, where the delivery of care via telemedicine...
Foley & Lardner
On April 3, 2024, Senators Edward Markey (D-Mass.) and Elizabeth Warren (D-Mass.), chaired a Senate Health, Education, Labor, and Pensions (HELP) Subcommittee on Primary Health and Retirement Security field hearing...
Ogletree, Deakins, Nash, Smoak & Stewart
The Washington State Legislature's 2024 legislative session adjourned on March 7, 2024, concluding a busy sixty-day period that saw lawmakers introduce almost 1,200 bills—on education, public safety...
Hall Benefits Law
Columbus Regional Healthcare System, Inc., a Georgia company, and a class of some 6,800 retirement plan participants, recently advised a federal district...
Arnold & Porter
There are several aspects of the pharmaceutical industry's potential environmental footprint. Research and development require sophisticated equipment, controlled environments, and specialised materials.
Holland & Knight
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
WilmerHale
One of the most notable privacy law developments from 2023, in what was a landmark year for the field, was the passage of Washington state's My Health My Data Act.
Jones Day
The Situation: The Anti-Kickback Statute ("AKS") is a federal criminal statute that prohibits "knowingly and willfully" offering or paying remuneration to induce a person to order or make a referral...
Jones Day
In February 2024, the Department of Justice ("DOJ") announced the results of its 2023 False Claims Act ("FCA") enforcement efforts. Through those efforts, it obtained more than $2.6 billion in overall...
Lane Powell
On October 30, 2023, President Biden issued an Executive Order titled "Safe, Secure and Trustworthy Artificial Intelligence."1 The Executive Order begins with the pronouncement...
Jones Day
Health care providers in California should carefully monitor OHCA's activities and begin to plan for coming changes in their relations with health plans, health insurers, and other payers.
Bass, Berry & Sims
On March 13, Utah Governor Spencer Cox signed into law the Artificial Intelligence Policy Act (the Act), governing the use of generative artificial intelligence (AI)...
Foley Hoag LLP
Six months into the fiscal year, Congress has finally passed FY2024 appropriations. It was a painstaking process, which many expected to include policy victories that both sides could celebrate.
Holland & Knight
In this episode of "Counsel That Cares," bankruptcy attorney Tyler Layne is joined by Gibbins Advisors managing directors Clare Moylan and Ron Winters to discuss their company's annual healthcare bankruptcy report.
Arnold & Porter
The Department of Justice (DOJ) is breathing new life into False Claims Act (FCA) enforcement based on the Stark Law (Stark), 42 U.S.C. § 1395nn, also known as the Physician Self-Referral Law.
Greenberg Traurig, LLP
On April 17, 2023, the Washington State Legislature passed the "My Health My Data Act" (WMHMDA or the Act), which took effect for most companies March 31, 2024.
Fenwick
The U.S. Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) regulates medical devices, including software-as-a-medical-device (SaMD).